Monogram Biosciences Inc (MGRM)

[steviee]

Briefing.com...Lazard plugs MGRM for 2H07 (11 Ratings) 24-Aug-07 10:35 am
MGRM Monogram Biosciences' oncology franchise will garner increased attention in 2H07 - Lazard (1.68 +0.01)

Lazard says that following maraviroc's FDA approval and tropism testing mentioned on the label, all that is left for current HIV catalysts are the sales execution of maraviroc and Trofile. Firm believes MGRM's oncology franchise will garner increased attention in 2H07. Following the positive early data that was presented at A.S.C.O in June, firm looks forward to upcoming oncology assay catalysts: 1) additional VeraTag data, 2) scientific journal publications, and 3) corporate oncology partner announced. They believe MGRM's opportunity to secure oncology collaborations should surpass those it has in HIV.
Rate it:
awful/not related to \pooraveragegoodexcellent


bullcall56

View Messages

Ignore User

Report A